
FDA and NIH Invest $150M to Replace Animal Testing
The U.S. government just launched major initiatives to phase out animal testing in drug development, backing new methods that better simulate human biology. The FDA released new guidance while the NIH committed over $150 million to institutions pioneering alternatives.
















